Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | PLK1 | P53350 | 3/20 | 0.32 |
| ▸ | PLK3 | Q9H4B4 | 2/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.31 |
| ▸ | BID | P55957 | 1/20 | 0.31 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diatrizoic Acid SCHEMBL8859575 | 0.85 | LMNA (0.55) | LMNASMN1; SMN2TSHRMAPK1 | |
| Diatrizoic Acid SCHEMBL8508 | 0.83 | LMNA (0.67) | LMNASMN1; SMN2TSHRMAPK1 | |
| Diatrizoic Acid SCHEMBL6362397 | 0.82 | LMNA (0.65) | LMNASMN1; SMN2TSHRMAPK1 | |
| Diatrizoic Acid SCHEMBL8053758 | 0.82 | LMNA (0.65) | LMNASMN1; SMN2TSHRMAPK1 | |
| Diatrizoic Acid SCHEMBL5960726 | 0.82 | LMNA (0.65) | LMNASMN1; SMN2TSHRMAPK1 | |
| Diatrizoic Acid SCHEMBL3974126 | 0.82 | LMNA (0.65) | LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL8752140 | 0.80 | LMNA (0.67) | LMNASMN1; SMN2TSHRMAPK1 | |
| Hydrochloric Acid SCHEMBL8089018 | 0.78 | LMNA (0.65) | LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL11588043 | 0.76 | LMNA (0.59) | LMNASMN1; SMN2TSHRMAPK1 | |
| Ioxotrizoic Acid SCHEMBL37821 | 0.76 | LMNA (0.59) | LMNASMN1; SMN2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240091403-A1 | PARTICLES | MICROVENTION, INC. | 2024-03-21 | — | — | US | disclosed |
| US-11857694-B2 | Particles | MICROVENTION, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-20220176012-A1 | PARTICLES | MICROVENTION, INC. | 2022-06-09 | — | — | US | disclosed |
| US-11285240-B2 | Particles | MICROVENTION, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| US-10946100-B2 | Polymers including active agents | MICROVENTION, INC. (US) | 2021-03-16 | — | — | US | disclosed |
| US-20200397942-A1 | PARTICLES | MICROVENTION, INC. | 2020-12-24 | — | — | US | disclosed |
| US-10792390-B2 | Particles | MICROVENTION, INC. (US) | 2020-10-06 | — | — | US | disclosed |
| US-20200121824-A1 | PARTICLES | MICROVENTION, INC. | 2020-04-23 | — | — | US | disclosed |
| US-10543295-B2 | Particles | MICROVENTION, INC. (US) | 2020-01-28 | — | — | US | disclosed |
| US-20190343982-A1 | PARTICLES | MICROVENTION, INC. | 2019-11-14 | — | — | US | disclosed |
| US-10226533-B2 | Polymer filaments including pharmaceutical agents and delivering same | MICROVENTION, INC. (US) | 2019-03-12 | — | — | US | disclosed |
| EP-3137124-B1 | POLYMERS INCLUDING ACTIVE AGENTS | MICROVENTION INC (US) | 2019-01-09 | — | — | EP | disclosed |
| US-10155064-B2 | Particles | MICROVENTION, INC. (US) | 2018-12-18 | — | — | US | disclosed |
| US-20180147317-A1 | PARTICLES | MICROVENTION, INC. | 2018-05-31 | — | — | US | disclosed |
| US-9907880-B2 | Particles | MICROVENTION, INC. | 2018-03-06 | — | — | US | disclosed |
| EP-3137124-A1 | POLYMERS INCLUDING ACTIVE AGENTS | Microvention, Inc. (US) | 2017-03-08 | — | — | EP | disclosed |
| WO-2016154592-A1 | EMBIOLIC PARTICLES | MICROVENTION, INC. (US) | 2016-09-29 | — | — | WO | disclosed |
| US-20160279282-A1 | PARTICLES | MICROVENTION, INC. | 2016-09-29 | — | — | US | disclosed |
| WO-2015167752-A1 | POLYMERS INCLUDING ACTIVE AGENTS | MICROVENTION, INC. (US) | 2015-11-05 | — | — | WO | disclosed |
| US-20150306227-A1 | POLYMERS INCLUDING ACTIVE AGENTS | MICROVENTION, INC. | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10226533-B2 | Polymer filaments including pharmaceutical agents and delivering same | MFAP1, ACTB, MAPT | LMNA 243/4885SMN1; SMN2 494/4885SLC22A1 4181/4885 |
| US-10946100-B2 | Polymers including active agents | MFAP1, VCL, ACTB | LMNA 199/4885SMN1; SMN2 1078/4885SLC22A1 4647/4885 |
| US-20150306227-A1 | POLYMERS INCLUDING ACTIVE AGENTS | MFAP1, VCL, ACTB | LMNA 199/4885SMN1; SMN2 1078/4885SLC22A1 4647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.